| Product dosage: 2mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.03 | $40.31 (0%) | 🛒 Add to cart |
| 20 | $2.52 | $80.61 $50.38 (38%) | 🛒 Add to cart |
| 30 | $2.02 | $120.92 $60.46 (50%) | 🛒 Add to cart |
| 60 | $1.34 | $241.83 $80.61 (67%) | 🛒 Add to cart |
| 90 | $1.23 | $362.75 $110.84 (69%) | 🛒 Add to cart |
| 120 | $1.18 | $483.66 $141.07 (71%) | 🛒 Add to cart |
| 180 | $0.90 | $725.49 $161.22 (78%) | 🛒 Add to cart |
| 270 | $0.82 | $1088.24 $221.68 (80%) | 🛒 Add to cart |
| 360 | $0.80
Best per pill | $1450.99 $287.17 (80%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
zanaflex
Tizanidine hydrochloride, marketed under the brand name Zanaflex, represents a centrally acting alpha-2 adrenergic agonist primarily indicated for the management of spasticity. When I first encountered this medication during my neurology rotation back in 2008, I’ll admit I was skeptical—we had baclofen and diazepam as our go-to agents, so why bother with another muscle relaxant? But watching Mrs. Gable, a 68-year-old multiple sclerosis patient, transition from being essentially bedbound to walking with a walker within two weeks of starting tizanidine completely changed my perspective.
lioresal
Baclofen, marketed under the brand name Lioresal among others, is a medication primarily used to manage spasticity. It’s a gamma-aminobutyric acid (GABA) derivative, specifically a GABAB receptor agonist. This isn’t your typical over-the-counter supplement; it’s a potent prescription drug that directly modulates the central nervous system. Its development marked a significant shift from older, more sedative antispasticity agents, offering a more targeted approach to managing muscle hypertonia and spasms that can be debilitating in conditions like multiple sclerosis, spinal cord injuries, and cerebral palsy.
robaxin
Robaxin, known generically as methocarbamol, is a centrally-acting skeletal muscle relaxant that’s been in clinical use for decades. It’s not your typical dietary supplement but rather a prescription medication with a well-established role in managing acute musculoskeletal pain. What’s fascinating about methocarbamol is how it occupies this unique space between simple analgesics and more potent opioids - giving us a valuable tool for those moderate pain cases where we want to avoid narcotics.
Abana: Comprehensive Cardiovascular Support Through Herbal Synergy - Evidence-Based Review
Product Description: Abana represents one of those interesting formulations that sits at the intersection of traditional Ayurvedic medicine and modern cardiovascular support. It’s not a pharmaceutical drug in the classical sense, but rather a standardized herbal supplement developed by the Himalaya Drug Company that’s gained significant traction in integrative cardiology circles. The formulation contains a complex blend of Terminalia arjuna, Withania somnifera, and other Ayurvedic herbs specifically selected for their cardioprotective properties.
Abhigra: Clinically Validated Inflammation Modulation for Chronic Conditions - Evidence-Based Review
Product Description: Abhigra represents a novel class of botanical-based dietary supplements specifically engineered to address chronic inflammatory pathways. Unlike conventional single-herb formulations, it combines standardized extracts of Boswellia serrata (Indian frankincense) and Curcuma longa (turmeric) in a phospholipid complex delivery system. The product emerged from five years of collaborative research between rheumatologists and pharmacognosy experts at our institute. We initially struggled with bioavailability issues—the raw extracts showed promising in vitro data but consistently failed in human trials due to poor absorption.
abilify
Aripiprazole, marketed under the brand name Abilify, represents a significant advancement in psychopharmacology as a second-generation antipsychotic medication. Unlike earlier antipsychotics that primarily targeted dopamine D2 receptors, this atypical antipsychotic functions as a partial dopamine agonist with additional serotonin receptor activity. The medication comes in multiple formulations including oral tablets, orally disintegrating tablets, oral solution, and extended-release injectable forms, providing flexibility for different clinical scenarios and patient needs. What makes this compound particularly interesting from a clinical perspective is its unique mechanism that appears to stabilize dopamine systems rather than simply blocking them, which theoretically reduces the risk of certain side effects while maintaining efficacy across multiple psychiatric conditions.
Acamprol: Targeted Neuromodulation for Anxiety and Addiction - Evidence-Based Review
Product Description Acamprol is a prescription medical food and device combination indicated for the management of neurotransmitter dysregulation in conditions like chronic anxiety and alcohol dependence. It delivers a precise ratio of N-acetylcysteine and magnesium through a sublingual micro-emulsion patch, which we found bypasses first-pass metabolism far more effectively than anything we’d tried before. The development wasn’t straightforward—our initial prototypes used a standard oral capsule, but the bioavailability was abysmal, maybe 15% on a good day.
Accufine: Advanced Continuous Glucose Monitoring for Diabetes Management - Evidence-Based Review
Before we get to the formal monograph, let me give you the real story on Accufine. I’ve been working with continuous glucose monitoring systems for about twelve years now, and when our research team first got our hands on the Accufine prototype, honestly, I was skeptical. We’d seen so many “revolutionary” glucose monitors come through our diabetes clinic that promised the moon and delivered mediocre accuracy once you got them on real patients with all their individual variations in skin thickness, hydration levels, and daily activity patterns.
Accupril: Effective Blood Pressure Control and Heart Failure Management - Evidence-Based Review
Accupril is a well-established pharmaceutical preparation, specifically an angiotensin-converting enzyme (ACE) inhibitor, containing quinapril hydrochloride as its active moiety. It’s not a dietary supplement or medical device but a prescription medication primarily indicated for the management of hypertension and as adjunctive therapy in heart failure. Its development stemmed from the need for ACE inhibitors with improved tissue penetration and a potentially more favorable side effect profile. The transition from earlier prototypes to the final quinapril formulation involved significant pharmacokinetic refinement to enhance its bioavailability and duration of action.